Melanoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Melanoma
Feb 10, 2024, 23:33 | Insight
Bettina Ryll: Got to kind of love the authors
Bettina Ryll, Founder of MPNEurope, shared a post by Marco Donia, Associate Professor at National Center for…
Feb 2, 2024, 18:01 | Blog
Richard Scolyer: Georgina and I deeply honoured to be named 2024 Australians of the Year!
Richard Scolyer, Co-medical director at the Melanoma Institute Australia, and Cojoint professor at the University of…
Jan 23, 2024, 10:44 | Insight
Joanna Baginska: The results for a melanoma expansion cohort of a phase 1B, multicenter, open-label study
Joanna Baginska, Lead Scientist at Dana-Farber Cancer Institute, shared a post on LinkedIn: "In this…
Dec 24, 2023, 18:05 | Insight
Marco Donia: Adjuvant Anti-PD-1 Immunotherapy for Resected Melanoma: Update December 2023
Marco Donia, Associate Professor at National Center for Cancer Immune Therapy, Denmark, shared on LinkedIn:…
Dec 11, 2023, 11:35 | Blog
Monica Bertagnolli assisted Stephanie Goff in a surgery as part of a clinical trial at NIH Clinical Center
Monica M. Bertagnolli shared on X/Twitter: "I recently assisted Dr. Stephanie Goff with a surgery…
Dec 7, 2023, 03:16 | Blog
Patrick Hwu: I'm so proud of his accomplishments over the years!
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared on X/Twitter: "Hussein Tawbi is…
Dec 6, 2023, 16:28 | Blog
Tracey O'Brien: Behind every statistic is a person whose life has changed forever
Tracey O'Brien shared on LinkedIn: "It’s easy to just focus on the numbers when talking about…
Nov 25, 2023, 18:19 | Blog
Dong-Woo Kang: Honored and excited to receive funding from WCRF/AICR
Dong-Woo Kang, an Instructor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute recently…
Nov 24, 2023, 15:42 | Blog
Dong-Woo Kang: Thrilled to receive an INSPIRE grant from World Cancer Research Fund/American Institute for Cancer Research
Dong-Woo Kang, an Instructor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute, recently…
Oct 31, 2023, 09:39 | Insight
Paolo A. Ascierto: The history of melanoma is changing!
Paolo A. Ascierto, Director Department of Melanoma/Skin Cancers, Cancer Immunotherapy and Development Therapeutics at IRCCS,…
Oct 13, 2023, 12:23 | Insight
Leticia Nogueira: If you think the greatest impact of Climate Change on Cancer is through increased risk of melanoma, read this article.
Leticia Nogueira, Director of Health Services Research at the American Cancer Society, shared on LinkedIn:…
Aug 20, 2023, 17:43 | Insight
Paola Anna Jablonska: We published the Princess Margaret Cancer Centre experience on toxicity of melanoma BMs.
Quoting Paola Anna Jablonska, Radiation Oncology Staff at Hospital Universitario de Navarra on LinkedIn: "We…
Aug 7, 2023, 19:00 | Blog
Massive congratulations Professor Georgina Long AO on this richly deserved honour recognising your incredible contributions in melanoma - Professor Richard Scolyer AO
Massive congratulations Professor Georgina Long AO on this richly deserved honour recognising your incredible contributions in…
Jul 10, 2023, 19:11 | Drugs
Today in Mexico City we launched the combination of encorafenib and binimetinib approved for adult patients with inoperable or metastatic melanoma positive at BRAF V600 mutation - Paolo A. Ascierto
Jul 3, 2023, 18:23 | Positive
Biked today to get in shape for breakthrough challenge to raise $ for cancer research - Lynn Schuchter
Biked today to get in shape for Breakthrough Challenge to raise $ for cancer research…
Jun 24, 2023, 16:29 | Stories
We have watched in Melanoma what happens if there is no coordination in access - Bettina Ryll
It was great to be part of the discussion and let's hope that this is…
All: 216 Posts: 201 - 300
Special Coverage